Organosyn lifesciences ltd

Prevention of invasive fungal infections during allogeneic bone marrow transplantation in patients with a high risk of this complication. Treatment of adults and children with: -      invasive aspergillosis; -      candidemia not accompanied by neutropenia; -      severe invasive infections caused by Candida (including C. krusei), resistant to fluconazole; -      severe fungal infections caused by Scedosporium and Fusarium species. As initial therapy in patients with progressive, potentially life-threatening infections.